Does the media refer more to GRDN or HNGE?

In the previous week, Hinge Health had 16 more articles in the media than Guardian Pharmacy Services. MarketBeat recorded 18 mentions for Hinge Health and 2 mentions for Guardian Pharmacy Services. Hinge Health's average media sentiment score of 0.26 beat Guardian Pharmacy Services' score of 0.09 indicating that Hinge Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Guardian Pharmacy Services 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Hinge Health 7 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to GRDN or CHE?

In the previous week, Chemed had 4 more articles in the media than Guardian Pharmacy Services. MarketBeat recorded 6 mentions for Chemed and 2 mentions for Guardian Pharmacy Services. Chemed's average media sentiment score of 1.01 beat Guardian Pharmacy Services' score of 0.09 indicating that Chemed is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Guardian Pharmacy Services 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Chemed 4 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor GRDN or HIMS?

In the previous week, Hims & Hers Health had 43 more articles in the media than Guardian Pharmacy Services. MarketBeat recorded 45 mentions for Hims & Hers Health and 2 mentions for Guardian Pharmacy Services. Guardian Pharmacy Services' average media sentiment score of 0.09 beat Hims & Hers Health's score of 0.09 indicating that Guardian Pharmacy Services is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Guardian Pharmacy Services 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Hims & Hers Health 3 Very Positive mention(s) 6 Positive mention(s) 32 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to GRDN or RDNT?

In the previous week, RadNet had 4 more articles in the media than Guardian Pharmacy Services. MarketBeat recorded 6 mentions for RadNet and 2 mentions for Guardian Pharmacy Services. RadNet's average media sentiment score of 0.59 beat Guardian Pharmacy Services' score of 0.09 indicating that RadNet is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Guardian Pharmacy Services 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral RadNet 2 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer LFST or GRDN?

In the previous week, LifeStance Health Group had 13 more articles in the media than Guardian Pharmacy Services. MarketBeat recorded 15 mentions for LifeStance Health Group and 2 mentions for Guardian Pharmacy Services. LifeStance Health Group's average media sentiment score of 0.76 beat Guardian Pharmacy Services' score of 0.09 indicating that LifeStance Health Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LifeStance Health Group 5 Very Positive mention(s) 1 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Guardian Pharmacy Services 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Guardian Pharmacy Services (GRDN) Competitors

$46.39 -1.61 (-3.36%)

Closing price 03:59 PM Eastern

Extended Trading

$45.59 -0.79 (-1.71%)

As of 07:59 PM Eastern

Compare

GRDN vs. HNGE, CHE, HIMS, RDNT, and LFST

Should you buy Guardian Pharmacy Services stock or one of its competitors? Guardian Pharmacy Services's main competitors and comparable companies include Hinge Health (HNGE), Chemed (CHE), Hims & Hers Health (HIMS), RadNet (RDNT), and LifeStance Health Group (LFST). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does Guardian Pharmacy Services compare to Hinge Health?

Guardian Pharmacy Services (NYSE:GRDN) and Hinge Health (NYSE:HNGE) are both mid-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, earnings, dividends, profitability, institutional ownership, risk and valuation.

Guardian Pharmacy Services has a beta of 0.06, meaning that its share price is 94% less volatile than the broader market. Comparatively, Hinge Health has a beta of 1.38, meaning that its share price is 38% more volatile than the broader market.

Guardian Pharmacy Services presently has a consensus price target of $43.83, indicating a potential downside of 5.51%. Hinge Health has a consensus price target of $101.93, indicating a potential upside of 9.09%. Given Hinge Health's higher possible upside, analysts plainly believe Hinge Health is more favorable than Guardian Pharmacy Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Guardian Pharmacy Services	0 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.89
Hinge Health	1 Sell rating(s)	2 Hold rating(s)	14 Buy rating(s)	1 Strong Buy rating(s)	2.83

Guardian Pharmacy Services has higher revenue and earnings than Hinge Health. Guardian Pharmacy Services is trading at a lower price-to-earnings ratio than Hinge Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Guardian Pharmacy Services	$1.45B	1.59	$49.22M	$1.03	45.04
Hinge Health	$587.86M	12.83	-$528.26M	$1.28	73.00

In the previous week, Hinge Health had 16 more articles in the media than Guardian Pharmacy Services. MarketBeat recorded 18 mentions for Hinge Health and 2 mentions for Guardian Pharmacy Services. Hinge Health's average media sentiment score of 0.26 beat Guardian Pharmacy Services' score of 0.09 indicating that Hinge Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Guardian Pharmacy Services	0 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Hinge Health	7 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Hinge Health has a net margin of 15.15% compared to Guardian Pharmacy Services' net margin of 4.50%. Hinge Health's return on equity of 51.60% beat Guardian Pharmacy Services' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Guardian Pharmacy Services	4.50%	29.97%	16.18%
Hinge Health	15.15%	51.60%	14.16%

Summary

Hinge Health beats Guardian Pharmacy Services on 11 of the 15 factors compared between the two stocks.

How does Guardian Pharmacy Services compare to Chemed?

Guardian Pharmacy Services (NYSE:GRDN) and Chemed (NYSE:CHE) are both mid-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, institutional ownership, risk, valuation, analyst recommendations, media sentiment, dividends and earnings.

In the previous week, Chemed had 4 more articles in the media than Guardian Pharmacy Services. MarketBeat recorded 6 mentions for Chemed and 2 mentions for Guardian Pharmacy Services. Chemed's average media sentiment score of 1.01 beat Guardian Pharmacy Services' score of 0.09 indicating that Chemed is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Guardian Pharmacy Services	0 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Chemed	4 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

95.9% of Chemed shares are held by institutional investors. 33.0% of Guardian Pharmacy Services shares are held by insiders. Comparatively, 3.3% of Chemed shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Guardian Pharmacy Services has a beta of 0.06, meaning that its stock price is 94% less volatile than the broader market. Comparatively, Chemed has a beta of 0.51, meaning that its stock price is 49% less volatile than the broader market.

Chemed has a net margin of 10.60% compared to Guardian Pharmacy Services' net margin of 4.50%. Chemed's return on equity of 31.77% beat Guardian Pharmacy Services' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Guardian Pharmacy Services	4.50%	29.97%	16.18%
Chemed	10.60%	31.77%	18.90%

Chemed has higher revenue and earnings than Guardian Pharmacy Services. Chemed is trading at a lower price-to-earnings ratio than Guardian Pharmacy Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Guardian Pharmacy Services	$1.45B	1.59	$49.22M	$1.03	45.04
Chemed	$2.53B	2.63	$265.24M	$19.91	25.59

Guardian Pharmacy Services currently has a consensus target price of $43.83, suggesting a potential downside of 5.51%. Chemed has a consensus target price of $530.75, suggesting a potential upside of 4.18%. Given Chemed's higher possible upside, analysts plainly believe Chemed is more favorable than Guardian Pharmacy Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Guardian Pharmacy Services	0 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.89
Chemed	0 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.17

Summary

Chemed beats Guardian Pharmacy Services on 12 of the 16 factors compared between the two stocks.

How does Guardian Pharmacy Services compare to Hims & Hers Health?

Guardian Pharmacy Services (NYSE:GRDN) and Hims & Hers Health (NYSE:HIMS) are both mid-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, media sentiment, dividends, valuation, analyst recommendations, institutional ownership, risk and profitability.

In the previous week, Hims & Hers Health had 43 more articles in the media than Guardian Pharmacy Services. MarketBeat recorded 45 mentions for Hims & Hers Health and 2 mentions for Guardian Pharmacy Services. Guardian Pharmacy Services' average media sentiment score of 0.09 beat Hims & Hers Health's score of 0.09 indicating that Guardian Pharmacy Services is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Guardian Pharmacy Services	0 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Hims & Hers Health	3 Very Positive mention(s)	6 Positive mention(s)	32 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Neutral

Guardian Pharmacy Services has a beta of 0.06, indicating that its stock price is 94% less volatile than the broader market. Comparatively, Hims & Hers Health has a beta of 2.42, indicating that its stock price is 142% more volatile than the broader market.

Guardian Pharmacy Services has a net margin of 4.50% compared to Hims & Hers Health's net margin of -5.51%. Guardian Pharmacy Services' return on equity of 29.97% beat Hims & Hers Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Guardian Pharmacy Services	4.50%	29.97%	16.18%
Hims & Hers Health	-5.51%	-6.51%	-1.20%

Guardian Pharmacy Services currently has a consensus target price of $43.83, indicating a potential downside of 5.51%. Hims & Hers Health has a consensus target price of $32.43, indicating a potential upside of 15.80%. Given Hims & Hers Health's higher possible upside, analysts clearly believe Hims & Hers Health is more favorable than Guardian Pharmacy Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Guardian Pharmacy Services	0 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.89
Hims & Hers Health	1 Sell rating(s)	12 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.13

Hims & Hers Health has higher revenue and earnings than Guardian Pharmacy Services. Hims & Hers Health is trading at a lower price-to-earnings ratio than Guardian Pharmacy Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Guardian Pharmacy Services	$1.45B	1.59	$49.22M	$1.03	45.04
Hims & Hers Health	$2.35B	2.78	$128.37M	-$0.63	N/A

63.5% of Hims & Hers Health shares are owned by institutional investors. 33.0% of Guardian Pharmacy Services shares are owned by company insiders. Comparatively, 11.8% of Hims & Hers Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Guardian Pharmacy Services beats Hims & Hers Health on 9 of the 16 factors compared between the two stocks.

How does Guardian Pharmacy Services compare to RadNet?

Guardian Pharmacy Services (NYSE:GRDN) and RadNet (NASDAQ:RDNT) are both mid-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, earnings, risk, valuation, analyst recommendations, profitability, institutional ownership and media sentiment.

Guardian Pharmacy Services has higher earnings, but lower revenue than RadNet. RadNet is trading at a lower price-to-earnings ratio than Guardian Pharmacy Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Guardian Pharmacy Services	$1.45B	1.59	$49.22M	$1.03	45.04
RadNet	$2.04B	2.92	-$18.65M	-$0.27	N/A

Guardian Pharmacy Services has a beta of 0.06, indicating that its stock price is 94% less volatile than the broader market. Comparatively, RadNet has a beta of 1.41, indicating that its stock price is 41% more volatile than the broader market.

In the previous week, RadNet had 4 more articles in the media than Guardian Pharmacy Services. MarketBeat recorded 6 mentions for RadNet and 2 mentions for Guardian Pharmacy Services. RadNet's average media sentiment score of 0.59 beat Guardian Pharmacy Services' score of 0.09 indicating that RadNet is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Guardian Pharmacy Services	0 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
RadNet	2 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

77.9% of RadNet shares are owned by institutional investors. 33.0% of Guardian Pharmacy Services shares are owned by insiders. Comparatively, 5.1% of RadNet shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Guardian Pharmacy Services has a net margin of 4.50% compared to RadNet's net margin of -0.93%. Guardian Pharmacy Services' return on equity of 29.97% beat RadNet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Guardian Pharmacy Services	4.50%	29.97%	16.18%
RadNet	-0.93%	2.61%	0.91%

Guardian Pharmacy Services presently has a consensus price target of $43.83, indicating a potential downside of 5.51%. RadNet has a consensus price target of $90.00, indicating a potential upside of 18.76%. Given RadNet's higher probable upside, analysts plainly believe RadNet is more favorable than Guardian Pharmacy Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Guardian Pharmacy Services	0 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.89
RadNet	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	2 Strong Buy rating(s)	2.89

Summary

Guardian Pharmacy Services and RadNet tied by winning 8 of the 16 factors compared between the two stocks.

How does Guardian Pharmacy Services compare to LifeStance Health Group?

LifeStance Health Group (NASDAQ:LFST) and Guardian Pharmacy Services (NYSE:GRDN) are both mid-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, profitability, valuation, institutional ownership, risk, dividends, earnings and analyst recommendations.

Guardian Pharmacy Services has higher revenue and earnings than LifeStance Health Group. Guardian Pharmacy Services is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LifeStance Health Group	$1.42B	3.43	$9.66M	$0.13	98.38
Guardian Pharmacy Services	$1.45B	1.59	$49.22M	$1.03	45.04

In the previous week, LifeStance Health Group had 13 more articles in the media than Guardian Pharmacy Services. MarketBeat recorded 15 mentions for LifeStance Health Group and 2 mentions for Guardian Pharmacy Services. LifeStance Health Group's average media sentiment score of 0.76 beat Guardian Pharmacy Services' score of 0.09 indicating that LifeStance Health Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
LifeStance Health Group	5 Very Positive mention(s)	1 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Guardian Pharmacy Services	0 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Guardian Pharmacy Services has a net margin of 4.50% compared to LifeStance Health Group's net margin of 3.19%. Guardian Pharmacy Services' return on equity of 29.97% beat LifeStance Health Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LifeStance Health Group	3.19%	3.39%	2.33%
Guardian Pharmacy Services	4.50%	29.97%	16.18%

85.5% of LifeStance Health Group shares are held by institutional investors. 3.5% of LifeStance Health Group shares are held by company insiders. Comparatively, 33.0% of Guardian Pharmacy Services shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

LifeStance Health Group has a beta of 1.22, meaning that its share price is 22% more volatile than the broader market. Comparatively, Guardian Pharmacy Services has a beta of 0.06, meaning that its share price is 94% less volatile than the broader market.

LifeStance Health Group currently has a consensus price target of $12.88, indicating a potential upside of 0.66%. Guardian Pharmacy Services has a consensus price target of $43.83, indicating a potential downside of 5.51%. Given LifeStance Health Group's higher possible upside, equities analysts plainly believe LifeStance Health Group is more favorable than Guardian Pharmacy Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LifeStance Health Group	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.73
Guardian Pharmacy Services	0 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.89

Summary

Guardian Pharmacy Services beats LifeStance Health Group on 9 of the 17 factors compared between the two stocks.

Get Guardian Pharmacy Services News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GRDN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

GRDN vs. The Competition

Export

Metric	Guardian Pharmacy Services	Healthcare Providers & Services Industry	Healthcare Sector	NYSE Exchange
Market Cap	$2.39B	$9.90B	$7.22B	$23.16B
Dividend Yield	N/A	2.60%	2.57%	3.59%
P/E Ratio	45.04	34.18	273.52	28.22
Price / Sales	1.59	4.98	647.05	20.04
Price / Cash	38.11	125.59	76.40	33.71
Price / Book	13.48	5.33	10.35	4.66
Net Income	$49.22M	$313.45M	$3.49B	$1.07B
7 Day Performance	6.58%	3.22%	-1.78%	-2.12%
1 Month Performance	20.85%	-0.42%	-1.48%	-4.92%
1 Year Performance	70.17%	17.09%	18.20%	8.27%

Guardian Pharmacy Services Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
GRDN Guardian Pharmacy Services	1.1697 of 5 stars	$46.39 -3.4%	$43.83 -5.5%	+62.1%	$2.39B	$1.45B	45.04	3,600
HNGE Hinge Health	3.3736 of 5 stars	$91.59 -1.2%	$101.93 +11.3%	+59.7%	$7.48B	$587.86M	71.56	1,437	News Coverage Insider Trade
CHE Chemed	4.4355 of 5 stars	$518.12 -0.2%	$530.75 +2.4%	+14.1%	$6.78B	$2.53B	26.02	15,811	Positive News
HIMS Hims & Hers Health	2.5095 of 5 stars	$27.81 -1.3%	$32.50 +16.9%	-48.4%	$6.57B	$2.35B	N/A	2,442	Trending News
RDNT RadNet	3.1429 of 5 stars	$70.87 -1.5%	$90.00 +27.0%	+2.8%	$5.66B	$2.04B	N/A	11,264

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:GRDN) was last updated on 9/16/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Guardian Pharmacy Services (GRDN) Competitors

GRDN vs. HNGE, CHE, HIMS, RDNT, and LFST

How does Guardian Pharmacy Services compare to Hinge Health?

Summary

How does Guardian Pharmacy Services compare to Chemed?

Summary

How does Guardian Pharmacy Services compare to Hims & Hers Health?

Summary

How does Guardian Pharmacy Services compare to RadNet?

Summary

How does Guardian Pharmacy Services compare to LifeStance Health Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

GRDN vs. The Competition

Guardian Pharmacy Services Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Guardian Pharmacy Services (GRDN) Competitors

GRDN vs. HNGE, CHE, HIMS, RDNT, and LFST

How does Guardian Pharmacy Services compare to Hinge Health?

Which has more risk and volatility, GRDN or HNGE?

Do analysts prefer GRDN or HNGE?

Which has better earnings and valuation, GRDN or HNGE?

Does the media refer more to GRDN or HNGE?

Is GRDN or HNGE more profitable?

Summary

How does Guardian Pharmacy Services compare to Chemed?

Does the media refer more to GRDN or CHE?

Do insiders and institutionals have more ownership in GRDN or CHE?

Which has more risk and volatility, GRDN or CHE?

Is GRDN or CHE more profitable?

Which has preferable valuation & earnings, GRDN or CHE?

Do analysts recommend GRDN or CHE?

Summary

How does Guardian Pharmacy Services compare to Hims & Hers Health?

Does the media favor GRDN or HIMS?

Which has more risk and volatility, GRDN or HIMS?

Is GRDN or HIMS more profitable?

Do analysts rate GRDN or HIMS?

Which has stronger earnings and valuation, GRDN or HIMS?

Do insiders & institutionals hold more shares of GRDN or HIMS?

Summary

How does Guardian Pharmacy Services compare to RadNet?

Which has better valuation and earnings, GRDN or RDNT?

Which has more volatility and risk, GRDN or RDNT?

Does the media refer more to GRDN or RDNT?

Do insiders and institutionals hold more shares of GRDN or RDNT?

Is GRDN or RDNT more profitable?

Do analysts rate GRDN or RDNT?

Summary

How does Guardian Pharmacy Services compare to LifeStance Health Group?

Which has stronger earnings & valuation, LFST or GRDN?

Does the media prefer LFST or GRDN?

Is LFST or GRDN more profitable?

Do institutionals and insiders believe in LFST or GRDN?

Which has more risk & volatility, LFST or GRDN?

Do analysts prefer LFST or GRDN?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

GRDN vs. The Competition

Guardian Pharmacy Services Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools